Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Pharma Mar SA ( (ES:PHM) ).
Pharma Mar SA has reported on its share buy-back program activities conducted between May 19 and May 23, 2025. During this period, the company purchased a total of 6,500 shares at varying prices on the BME trading center. This buy-back initiative is part of the company’s strategy to stabilize its stock and potentially enhance shareholder value.
The most recent analyst rating on (ES:PHM) stock is a Buy with a EUR108.00 price target. To see the full list of analyst forecasts on Pharma Mar SA stock, see the ES:PHM Stock Forecast page.
More about Pharma Mar SA
Pharma Mar SA is a company operating in the pharmaceutical industry, primarily focused on the development and commercialization of marine-derived drugs. The company is known for its innovative approach to drug discovery and has a significant presence in the oncology market.
YTD Price Performance: 5.33%
Average Trading Volume: 62,624
Technical Sentiment Signal: Buy
Current Market Cap: €1.51B
For an in-depth examination of PHM stock, go to TipRanks’ Stock Analysis page.